Allogeneic Hematopoietic Stem Cell Transplant in Elderly Patients Using Reduce Intensity Conditioning Regimen: A Single Centre Experience
Allogeneic stem cell transplantation (SCT) remains a cornerstone in the treatment strategy of most hematologic malignancies. Previously, age and comorbidities were considered limiting factors. With the introduction of reduced intensity conditioning regimens (RIC) and the understanding of donor immune function, allogeneic SCT in adults aged more than 60 years gained its place.
Source: Clinical Lymphoma, Myeloma and Leukemia - Category: Hematology Authors: Riwa Sakr, Sylvain Pilorge, Stephane Debotton, Claude Chahine, Tereza Coman, David Ghez, Alina Danu, Micol Jean-Baptiste, Florence Pasquier, Vincent Ribrag, Christophe Willekens, Eric Solary, Jean-Henri Bourhis, Cristina Castilla-Llorente Source Type: research
More News: Cancer & Oncology | Hematology | Leukemia | Lymphoma | Myeloma | Stem Cell Therapy | Stem Cells | Transplants